Stanozolol (also referred to by its brand name Winstrol) is a synthetic anabolic and androgen steroid used medically to treat hormone deficiencies and certain blood disorders, more commonly referred to as Winstrol.
Bodybuilders and athletes frequently utilize these substances to increase muscle mass, enhance strength, and extend endurance - often leading to doping violations in sports.
Binds to androgen receptors to promote protein synthesis. Due to structural modifications, its androgenic activity is reduced compared to that of testosterone.
Synthesized in 1960s through modification of dienones. Key intermediate involves cyclization of stanozolone derivatives.
Developed by Winthrop Laboratories in 1962. Approved by FDA in 1967 under brand name Winstrol.
Scheduled as a Schedule III controlled substance under CSA for anabolic steroid regulations. Requires prescription.
Banned by World Anti-Doping Agency (WADA) since inception of prohibited list. Sanctioned athletes face disqualification and suspensions.
Investigated for potential use in treating muscle-wasting conditions. Studies explore its role in pediatric growth disorders with caution due to side effects.